Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGGOF Galane Gold Ltd
GFY Western Asset Variable Rate Strategic Fund Inc
GEF Greif Inc
GE General Electric Co
GDXJ VanEck Vectors Junior Gold Miners ETF
GDX VanEck Vectors Gold Miners ETF
GD General Dynamics Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
$62.25
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
62.51
Day's Low
61.77
Volume
(Light)
Volume:
7,142,839

10-day average volume:
9,831,062
7,142,839

Lifshitz Law Firm, P.C. Announces Investigation of Benefytt Technologies, Inc., Delmarva Bancshares, Inc., Garrison Capital Inc., Portman Ridge Finance Corporation, Graf Industrial Corp., Invitae Corporation, Maxim Integrated Products, Analog Devices, Rexahn Pharmaceuticals, Inc., Vivint Solar, Inc. and Sunrun, Inc.

6:06 pm ET July 15, 2020 (PR Newswire) Print

Benefytt Technologies, Inc. (BFYT)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BFYT to Madison Dearborn Partners, LLC for $31.00 per share.

If you are a BFYT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Delmarva Bancshares, Inc. (DLMV)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of DLMV to BV Financial Inc. for $8.90 per share.

If you are a DLMV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Garrison Capital Inc. (GARS) - Portman Ridge Finance Corporation (PTMN)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of GARS to PTMN.

If you are a GARS or PTMN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Graf Industrial Corp. (GRAF)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger whereby GRAF will combine with Velodyne Lidar, Inc.

If you are a GRAF investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Invitae Corporation (NVTA)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the proposed merger between Invitae and ArcherDX.

If you are a NVTA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Maxim Integrated Products (MXIM) - Analog Devices (ADI)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the proposed merger of MXIM and ADI.

If you are a MXIM or ADI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Rexahn Pharmaceuticals, Inc. (REXN)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of REXN to Ocuphire Pharma, Inc.

If you are a REXN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Vivint Solar, Inc. (VSLR) - Sunrun (RUN)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of Vivint with Sunrun.

If you are a VSLR or SUN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.(C) 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:Joshua M. Lifshitz, Esq.Lifshitz Law Firm, P.C. Phone: 516-493-9780Facsimile: 516-280-7376Email: info@jlclasslaw.com

SOURCE Lifshitz & Miller Law Firm

https://rt.prnewswire.com/rt.gif?NewsItemId=DC64744&Transmission_Id=202007151535PR_NEWS_USPR_____DC64744&DateId=20200715

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.